Exosomal circ_0097112 drives icotinib resistance through activating RAF/MAPK signaling in lung adenocarcinoma
- 6 June 2026
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 146, 112652
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81902146)
- Ningbo University
- Natural Science Foundation of Ningbo Municipality (2023J077)
This publication has 25 references indexed in Scilit:
- Exosome-derived hsa_circ_0007132 promotes lenvatinib resistance by inhibiting the ubiquitin-mediated degradation of NONONon-coding RNA Research, 2025
- UPF1 plays critical roles in early B cell developmentNature Communications, 2024
- Psychodermatology of Chronic Pruritus: An Overview of the Link Between Itch and DistressDermatology and Therapy, 2024
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Circular RNAs in chemotherapy resistance of lung cancer and their potential therapeutic applicationIUBMB Life, 2022
- The role of H19 lncRNA in conferring chemoresistance in cancer cellsBiomedicine & Pharmacotherapy, 2021
- The biology , function , and biomedical applications of exosomesScience, 2020
- Exosomes transmit T790M mutation‐induced resistance in EGFR‐mutant NSCLC by activating PI3K/AKT signalling pathwayJournal of Cellular and Molecular Medicine, 2020
- Exosomes in cancer development, metastasis, and immunityBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitorsAnnals of Oncology, 2018